| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c7159366be37ecf8a4c595cfa235a8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-52 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate |
1991-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb8e643ce8bd58bf212801b06b003138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac41b77c9873917ebcedc24ee338cfc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ad95693cf7fef1fcafbbd1596bcc060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e689f3b840b091db920320de104e5b64 |
| publicationDate |
1993-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H0578397-A |
| titleOfInvention |
Thrombolytic protein |
| abstract |
(57) [Summary] [Object] To provide a novel thrombolytic protein having a high thrombus specificity and exhibiting an anticoagulant effect. [Structure] The thrombolytic protein of the present invention comprises a tissue plasminogen activator or a modified form thereof and a part or all of the epidermal growth factor-like domain of thrombomodulin directly or via a linker. It is a hybrid and is prepared by a gene recombination technique. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005538046-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0966545-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0714982-A3 |
| priorityDate |
1991-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |